Carr
Long

$ACAD chart update post-$BIIB

NASDAQ:ACAD   ACADIA PHARMACEUTICALS INC
35 0 1
The $BIIB buyout story has put a bid under other key biotech buyout targets like $ACAD. Chart shows a steady accumulation within a bullish channel in a modest uptrend.
Check out our sites: DrStoxx.com and DrStoxxTrading.com
English
English (UK)
English (IN)
Deutsch
Français
Español
Italiano
Polski
Türkçe
Русский
Português
Bahasa Indonesia
Bahasa Melayu
ภาษาไทย
Tiếng Việt
日本語
한국어
简体中文
繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out